42 results about "Cannabis product" patented technology

A cannabis product updated user feedback system and method that informs users of the anticipated psychological and physiological effects of a cannabis product. The system includes the creation of an effects graph associated with the cannabis product that may be distributed with the cannabis product or presented on a website. The effects graph includes one or more line graphs depicting the effects and interactions experienced by all reporting users of the product. The system includes a website in which the feedback information regarding a particular cannabis product is collected. The administrator of the website then reviews the feedback information and provides updated line graph data. Each line graph shows the intensity of user-reported effects graded from 0 to an upper limit on the y axis over a time presented on the x axis. The effects graph may include icons that visually portray what a user consumed and how they felt. By viewing the line graph, a user can anticipated the effects, the intensity, when they occur and the duration.

In one aspect, a formulation comprising cannabinoids, paracetamol, methylxanthines, salicylates, terpenes, humulus oil, or amino acids individually or any combination or omission thereof for the reduction, alleviation, elimination, and/or suspension of effects of THC exposure and anxiety. The formulation can be the effective amount of cannabinoid is between 5 mg and 5000 mg. The formulation can be the cannabinoid comprises a Cannabidiol (CBD), a cannabidolic acid (CBDA), a Cannabinol (CBN), a Cannabigerol (CBG), a Cannabichromene (CBC), a Cannabicyclol (CBL), a Cannabivarin (CBV), a Tetrahydrocannabivarin (THCV), a Cannabidivarin (CBDV), a Cannabichromevarin (CBCV), a Cannabigerovarin (CBGV), a Cannabigerol monomethyl ether (CBGM), a Cannabielsoin (CBE), or a cannabicitran (CBT). The formulation can be the effective amount of paracetamol is between 0 mg-1000 mg.

Cannabis products and industrial methods for production thereof. A homogeneous composition comprising cannabinoid-containing comminuted cannabis plant material, where at least 70 weight % of the comminuted cannabis plant material is of a size greater than 0.3 millimeter and less than 4.2 millimeters; the composition comprises at least 1% by weight moisture and less than 20% by weight moisture; and the cannabinoid concentration in a 1 gram fraction of at least 10 gram sample of said homogeneous composition, is within 15% of the cannabinoid concentration in a separate 1 gram fraction of said 10 gram sample.

The invention provides for a system to track the origin of cannabis products and cannabis derivative products without the need for packaging or labeling through the use of nucleic acid tags. The invention further provides for a method of tracking the origin of cannabis products and cannabis derivative products via the application of nucleic acid tags to cannabis plants.

An oral disintegrating film including a cannabinoid or cannabinoid analogue, a first film forming polymer and a solubilizing agent are disclosed as well as methods of using same.

The present invention provides methods of extraction of at least one cannabinoid from an initial cannabis biomass in “one-pot” step using toluene to form a toluene extract and using the toluene extract for producing high concentrations of Δ-9-tetrahydrocannabinol (Δ9THC) and/or cannabinol (CBN) of a purity of at least 75% and at a yield of at least 75% by weight of the at least one cannabinoid from the initial cannabis biomass in the toluene extract.

Provided is a system and method for educating medical practitioners as to why they should recommend the use of medical cannabis to their patients, how they can incorporate medical cannabis into their practices, how they can recommend the use of medical cannabis to their patients safely, efficiently, profitably, legally and without fear of professional liability, how patients can be directed to their practices, how the owner of the method or system can: i)consult with the medical practitioners to build and design a medical cannabis practice for them and provide initial operational training for them; and ii) jointly develop, own and operate a medical cannabis practice that is managed by the owner of the method or system. Also provided is a system and method for educating patients as to the medical benefits of cannabis, how they can qualify for their Medical Marijuana ID Cards, and how they can be referred to certain physicians and dispensaries. Further provided is a system and method for cannabis product growers, processors and sellers with access to the system to communicate directly with physicians and patients having access to the system and facilitate business with them. Also provided is a system and method for lawyers, insurers, electronic medical record service providers, and other vendors with access to the system to market their goods or services to medical cannabis practitioners, medical cannabis patients, and cannabis product growers, processors and dispensers. Also provided is a system to provide a database of all information relating to medical cannabis.

Through a physician's portal, a platform calculates efficacy ratings for patient records matching a medical condition and generates reports. The physician uses the reports to create a cannabis treatment prescription for the patient, which is stored in the patient's record. An electronic notification message is sent to the patient with a unique access code, which the patient may use to retrieve the cannabis treatment prescription via a patient's portal. After the patient obtains cannabis products, the patient inputs cannabis treatment data via the patient's portal, including cannabis profile of the cannabis products and a patient efficacy rating, which are stored in the patient's record. The physician retrieves the cannabis treatment data via the physician's portal and optionally modifies the prescription. The patient retrieves the modified prescription via the patient's portal. In this manner, networking communication channels between physician and patient for cannabis treatment and result data are provided.

A system, method and device that allows medically prescribed cannabis products, such as individual cigarettes, e-cigarettes or cannisters, to be tracked, registered, identified and matched with both legal prescriptions and the patients themselves, such that law enforcement may readily determine if an individual is legally in possession of a medically prescribed cannabis product.

The invention comprises a method and/or an apparatus for operating a Cannabis facility generating a tetrahydrocannabinol (THC) containing product, comprising the step of labeling the THC containing product with a matrix bar code/quick response (QR) code, the cannabis containing product comprising at least two milligrams of a tetrahydrocannabinol substance, the QR code linking to product information associated with the THC containing product, the product information comprising at least one of a location, date of harvest, strain, and/or type of a plant containing a tetrahydrocannabinol substance in the THC containing product; an extraction method; a date and/or a location of manufacture of the THC product; a related laboratory report; and/or a link to a related web page.

The invention discloses a fructus cannabis processing production process which comprises the following steps: firstly, shucking cleaned and classified fructus cannabis seeds, peeling a shucked mixed material for the first time, peeling for the second time, and conducting separation treatment repeatedly for a plurality of times so as to separate large peel, small peel and various impurities in the mixed material, feeding back the separated fructus cannabis seeds to the shucking procedure, and quantitatively packaging the separated fructus cannabis seeds which meet the quality standard, thereby obtaining a finished fructus cannabis product. The fructus cannabis processing production process has the advantages that the fructus cannabis is subjected to shucking treatment according to the characteristics of fructus cannabis self, separators of different structures and principles are adopted to peel and separate fructus cannabis seeds for multiple times so as to obtain fructus cannabis with very high purity, the peel content of the finished fructus cannabis product is lower than 0.2%, the content of green peel is lower than 0.5%, procedures are mechanically connected, the production efficiency is improved, the treatment capacity is 1.5 ton per hour, continuous mechanical production can be conducted, and convenient conditions are provided for deep processing and industrialization of fructus cannabis.

The system and method of the present invention provides an automated washing and extraction system and method to removed trichomes from cannabis product to create hash resin. Inconsistency is removed from the hash extraction process by automating the washing and extraction cycles thereof. The system and method records the data and tracks all user functions. Manual labor is removed or significantly reduced and time to create the final product is greatly lessened. Thus, more hash can be produced in a shorter amount of time. Moreover, the present invention allows the end user a controlled and accurate and efficient way of producing large quantities of solvent-free hash in a short amount of time while doing so in a consistent, repeatable and cost-effective manner.

A system and methods for network-enabled cannabis product delivery, comprising at least a plurality of network-enabled portals for data entry, legality and identification checks, and more, allowing a user to order delivery of cannabis products from local retailers using third-party drivers that register with the system, for compensation, and allowing for feedback and automated communication between a retailer, driver, and customer using the system.

A system and method for testing the potency of a Cannabis feedstock used in the manufacture of Cannabis-infused foods and beverages are disclosed herein. The system and methods can include at least one sensor capable of detecting cannabinoid compounds. The testing method can include a first test on the incoming Cannabis active ingredients to determine the incoming cannabinoid levels. The results of the first test are used in an algorithm to determine the process steps to incorporate the feedstock into the manufacture of an edible Cannabis product while maintaining a predetermined cannabinoid level in the final product.

The present invention provides app users the ability to view and share prices for popular products sold in cannabis dispensaries. Users can also submit and view reviews for each dispensary. The map feature allows users the ability to quickly view prices.

Methods and systems for testing Cannabis vaping liquid for liquid vaporizers and vaporizer devices to ensure compliance with product quality are disclosed. The methods and systems allow Cannabis extractors to test Cannabis vaping liquids produced with the Cannabis extract by using a universal attachment couplable with a vaporizer device at various settings of the vaporizer device. The test results can be stored in the cloud accessible by Cannabis extractors, Cannabis-infused product producers, vaporizer device manufacturers, and end users so that the quality data of the vaping liquid and optimum vaporizer settings are easily determined.

Methods and systems for quantifying a variety of cannabis concentrate attributes relating to potency of a cannabis derivative product are disclosed. The methods and systems further generate a standard index rating to be affixed to a label for a cannabis concentrates and/or cannabis-infused products. The methods and systems include an extractor network, a product labeling system, and a user device coupled via a communication network. The product labeling system operable to analyze a cannabis product and receive additional input from a user application and store information relating to a cannabis product for consumers to review.

A system and method for providing a Cannabis product with a product label describing the onset of effects. The product label may include key consumption information such as time after consumption until the product takes effect, types of effects, time until effect subsides, effect on other functions (e.g., sleep, eating, working, reading), and best use cases for the Cannabis product. The system may include crowdsourcing data of Cannabis product effects from users to determine the effect to the average user. In some embodiments, the label may describe separate effects for users at various levels of tolerance.

The present invention relates to a system and method using a computer implemented application or a website for facilitating the creation and ordering of cannabis related products. The system can be used by customers for customizing their cannabis or marijuana farming choices via selection of seeds, strains, THC levels, and more. The system enables sellers to receive customized orders from the customers and the orders are processed and dispatched through delivery partners or clients. In one example, a customer selects functions and performs a purchase to enable the customer to purchase cannabis products. The client or seller receives the customer order and dispatches the order. A plurality of back-end users manage the system by monitoring sales, purchases, onboarding of customers and clients, and more.

The present application relates to the production of cannabis products, particularly on a large scale, such as at an industrial level. Cannabis is typically a controlled and regulated substance, and so inventory control, security, and traceability of the cannabis may need to be provided. A human-based manual and/or labor-intensive implementation is not scalable, and is therefore infeasible at an industrial level. Disclosed herein are computer systems for inventory control, security systems, and computer methods for facilitating traceability from a cannabis product back to a batch of cannabis plants.